Literature DB >> 16166431

DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma.

Jun Zhang1, Ciro R Martins, Zoya B Fansler, Kristina L Roemer, Erik A Kincaid, Karen S Gustafson, Daniel F Heitjan, Douglas P Clark.   

Abstract

PURPOSE: Anal intraepithelial neoplasia is associated with human papillomavirus infection and may progress to invasive squamous cell carcinoma (SCC), which is increasing in immunocompromised patients. We hypothesize that anal intraepithelial neoplasia is associated with abnormal DNA methylation and that detection of these events may be used to improve screening programs. EXPERIMENTAL
DESIGN: Seventy-six patients were identified who underwent anal cytology screening and subsequent biopsy at our institution between 1999 and 2004. The specimens from these patients included 184 anal biopsies [normal, n = 57; low-grade squamous intraepithelial lesion (LSIL), n = 74; high-grade squamous intraepithelial lesion (HSIL), n = 41; and invasive SCC, n = 12] and 37 residual liquid-based anal cytology specimens (normal, n = 11; LSIL, n = 12; HSIL, n = 14). The methylation status of the following genes was determined for each biopsy and cytology sample using real-time methylation-specific PCR: HIC1, RASSF1, RARB, CDKN2A, p14, TP73, APC, MLH1, MGMT, DAPK1, and IGSF4.
RESULTS: Methylation-specific PCR analysis of biopsy samples revealed that DNA methylation was more common in SCC and HSIL than LSIL and normal mucosa. Specifically, methylation of IGSF4 and DAPK1 was prevalent in SCC (75% and 75% of cases, respectively) and HSIL (59% and 71%, respectively) but was absent in LSIL and normal biopsy samples. Methylation profiles of cytologic samples were similar to those found in the biopsy samples.
CONCLUSIONS: Aberrant DNA methylation is a frequent event in anal HSIL and SCC. Methylation of IGSF4 and DAPK1 is specific for HSIL and SCC, and may serve as a useful molecular biomarker.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16166431     DOI: 10.1158/1078-0432.CCR-05-0374

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  14 in total

1.  Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression.

Authors:  Doerthe Kuester; Altaf A Dar; Christopher C Moskaluk; Sabine Krueger; Frank Meyer; Roland Hartig; Manfred Stolte; Peter Malfertheiner; Hans Lippert; Albert Roessner; Wael El-Rifai; Regine Schneider-Stock
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

Review 2.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

Review 3.  Current understanding and potential immunotherapy for HIV-associated squamous cell carcinoma of the anus (SCCA).

Authors:  Christian Marin-Muller; Min Li; Changyi Chen; Qizhi Yao
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

4.  Pilot Study of Markers for High-grade Anal Dysplasia in a Southern Cohort From the Women's Interagency Human Immunodeficiency Virus Study.

Authors:  Cecile D Lahiri; Minh Ly Nguyen; C Christina Mehta; Marina Mosunjac; Talaat Tadros; Elizabeth R Unger; Mangalathu S Rajeevan; Jendai Richards; Ighovwerha Ofotokun; Lisa Flowers
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

5.  HIC1 regulates tumor cell responses to endocrine therapies.

Authors:  Baohua Zhang; Douglas V Faller; Sheng Wang
Journal:  Mol Endocrinol       Date:  2009-10-09

6.  Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study.

Authors:  Erin M Siegel; Steven Eschrich; Kathryn Winter; Bridget Riggs; Anders Berglund; Abidemi Ajidahun; Jeff Simko; Jennifer Moughan; Jaffer Ajani; Anthony Magliocco; Abul Elahi; Sarah Hoffe; David Shibata
Journal:  Dis Colon Rectum       Date:  2014-08       Impact factor: 4.585

Review 7.  Therapeutic targets in the ARF tumor suppressor pathway.

Authors:  Anthony J Saporita; Leonard B Maggi; Anthony J Apicelli; Jason D Weber
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

8.  DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.

Authors:  Yin Sun; Shu Li; Keng Shen; Shuang Ye; Dongyan Cao; Jiaxin Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  Cancer Risk Stratification of Anal Intraepithelial Neoplasia in Human Immunodeficiency Virus-Positive Men by Validated Methylation Markers Associated With Progression to Cancer.

Authors:  Ramon P van der Zee; Olivier Richel; Carel J M van Noesel; Iuliana Ciocănea-Teodorescu; Annina P van Splunter; Timo J Ter Braak; Mayura Nathan; Tamzin Cuming; Michael Sheaff; Alexander Kreuter; Chris J L M Meijer; Wim G V Quint; Henry J C de Vries; Jan M Prins; Renske D M Steenbergen
Journal:  Clin Infect Dis       Date:  2021-06-15       Impact factor: 9.079

10.  DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia.

Authors:  Jonathan M Hernandez; Erin M Siegel; Bridget Riggs; Steven Eschrich; Abul Elahi; Xiaotao Qu; Abidemi Ajidahun; Anders Berglund; Domenico Coppola; William M Grady; Anna R Giuliano; David Shibata
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.